Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals

Heart

Volumn 95, Issue 18, 2009, Pages 1514-1519

  Schou, Morten ^a   Alehagen, U ^b   Goetze, J P ^c   Gustafsson, F ^c   Dahlstrom, U ^b  

^a HILLERØD HOSPITAL   (Denmark)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; IMMUNOASSAY; KIDNEY DISEASES; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 69549117340     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.173666     Document Type: Article

References (32)

1. Luchner A, Hengstenberg C, Lowel H, et al. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005;46:118-123 (Pubitemid 40946501)
2. Schou M, Gustafsson F, Kistorp CN, et al. Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients. Clin Chem 2007;53:1928-1935 (Pubitemid 350036037)
3. Raymond I, Gronning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma concentration of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-751 (Pubitemid 36760633)
4. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol 1997;47:287-296
5. Schou M, Dalsgaard MK, Clemmesen O, et al. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 2005;99:1676-1680 (Pubitemid 41547162)
6. Goetze JP, Jensen G, Moller S, et al. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 2006;36:8-15.
7. van Kimmenade RR, Januzzi JL Jr, Bakker JA, et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol 2009;53:884-890
8. Hammerer-Lercher A, Halfinger B, Sarg B, et al. Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure. Clin Chem 2008;54:858-865 (Pubitemid 351671596)
9. Hejmdal A, Boesgaard S, Lindholm MG, et al. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock. J Card Fail 2007;13:184-188 (Pubitemid 46590035)
10. Alehagen U, Lindstedt G, Eriksson H, et al. Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care. Clin Chem 2003;49:1337-1346 (Pubitemid 36900620)
11. Alehagen U, Lindestedt G, Levin LA, et al. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population. Int J Cardiol 2005;100:125-133 (Pubitemid 40487946)
12. Troughton RW, Prior DL, Pereira JJ, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004;43:416-422 (Pubitemid 38167702)
13. Shulz H, Langvik TA, Lund Sagen E, et al. Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma. Scand J Clin Lab 2001;61:33-42. (Pubitemid 32240871)
14. Yeo KT, Wu AH, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP immunoassay and comparison to the Biosite Triage BNP immunoassay. Clin Chim Acta 2003;338:107-115
15. Goetze JP. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 2004;50:1503-1510
16. Goetze JP, Dahlstrom U, Rehfeldt JH, et al. Impact of epitope specificity and precursor maturation in pro-B-type natriuretic peptide measurement. Clin Chem 2008;54:1780-1787
17. Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007;18:2749-2757 (Pubitemid 47531202)
18. Maisel A, Muller C, Adams K jr, et al. State of the art: using natriuretic peptide concentrations in clinical practice. Eur J Heart Fail 2008;10:824-839
19. Ala-Kopsala M, Magga J, Peuhkurinen K, et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004;50:576-588 (Pubitemid 39121226)
20. Das SR, Abdullah SM, Leonard D, et al. Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study). Am J Cardiol 2008;102:1394-1398
21. Shelton RJ, Clark AL, Goode K, et al. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J 2006;27:2353-2361 (Pubitemid 44461764)
22. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442
23. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.
24. Prontera C, Zaninotto M, Giovannini S, et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study. Clin Chem Lab Med 2009;47:762-768
25. Rosenberg J, Schou M, Gustafsson F, et al. Prognostic threshold levels of NT-proBNP testing in primary care. Eur Heart J 2009;30:66-73.
26. Ingle L, Rigby AS, Carroll S, et al. Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 2007;28:560-568 (Pubitemid 47355515)
27. Olsson LG, Swedberg K, Cleland JG, et al. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial. Eur J Heart Fail 2007;9:795-801. (Pubitemid 47225165)
28. Wedel H, McMurray JJ, Lindberg M, et al. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail 2009;11:281-291
29. Buchner S, Muscholl M, Debl K, et al. Left atrial size by planimetry is superior to M-mode diameter: biochemical calibration by atrial and brain natriuretic peptide. J Am Soc Echocardiogr 2008;21:380-385
30. Smith GD, Phillips AN. Confounding in epidemiological studies: why "independent" effects may not be all they seem. BMJ 1992;305:757-759
31. Smilde TD, van Veldhuisen DJ, Navis G, et al. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006;114:1572-1580 (Pubitemid 44547427)
32. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996;25:1107-1116 (Pubitemid 27013514)